<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00787553</url>
  </required_header>
  <id_info>
    <org_study_id>920/2006</org_study_id>
    <nct_id>NCT00787553</nct_id>
  </id_info>
  <brief_title>Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy</brief_title>
  <official_title>Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campinas, Brazil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: to compare the efficacy of tinidazole and cefazolin on the prophylaxis of the
      febrile and infectious morbidity after vaginal or abdominal hysterectomy. Methods: A
      randomized clinical trial carried out at the Women's Integrated Healthcare Center
      (CAISM)/UNICAMP, Campinas, Brazil. Women undergoing to total vaginal or abdominal
      hysterectomy were randomly enrolled into one of these three groups of antibiotic prophylaxis:
      tinidazole, cefazolin or an association of both.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized clinical trial carried out at the Women's Integrated Healthcare Center
      (CAISM)/UNICAMP, Campinas, Brazil, to compare the efficacy of tinidazole and cefazolin on the
      prophylaxis of the febrile and infectious morbidity after vaginal or abdominal hysterectomy.
      Women undergoing to total vaginal or abdominal hysterectomy were randomly enrolled into one
      of these three groups of antibiotic prophylaxis: tinidazole, cefazolin or an association of
      both.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2006</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative infection</measure>
    <time_frame>one month after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>cefazolin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>tinidazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>cefazolin plus tinidazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefazolin</intervention_name>
    <description>2.0 g, IV, 2 hours before surgery</description>
    <arm_group_label>cefazolin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tinidazole</intervention_name>
    <description>2.0 g orally, 12 hours before surgery</description>
    <arm_group_label>tinidazole</arm_group_label>
    <other_name>imidazoles</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefazolin plus tinidazole</intervention_name>
    <description>cefazolin, 2.0 g IV 2 hours before surgery plus tinidazole 2.0 g orally 12 hours before surgery</description>
    <arm_group_label>cefazolin plus tinidazole</arm_group_label>
    <other_name>cefazolin</other_name>
    <other_name>tinidazole</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women undergoing to hysterectomy due to non-oncologic causes

        Exclusion Criteria:

          -  previous pelvic infection

          -  antibiotic use within 7 days before surgery

          -  study drugs allergy

          -  immuno-incompetence

          -  urinary tract infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>32 Years</minimum_age>
    <maximum_age>72 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose A Simoes, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Campinas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Campinas</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13083-970</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2008</study_first_submitted>
  <study_first_submitted_qc>November 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2008</study_first_posted>
  <last_update_submitted>November 6, 2008</last_update_submitted>
  <last_update_submitted_qc>November 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Jose Antonio Simoes</name_title>
    <organization>University of Campinas, Brazil</organization>
  </responsible_party>
  <keyword>hysterectomy</keyword>
  <keyword>antibiotic prophylaxis</keyword>
  <keyword>bacterial vaginosis</keyword>
  <keyword>tinidazole</keyword>
  <keyword>cefazolin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Cefazolin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Tinidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

